DePuy Synthes unveils new surgical imaging system that cuts costs

J&J’s DePuy Synthes unveiled its latest surgical imaging offering that’s designed to be more affordable in hopes of opening up access to advanced imaging tech.

Dubbed the KICK System with FluoroExpress Software Module, the package is compatible with the VIPER System and the EXPEDIUM Spine System of implants, and improved visualization during minimally invasive and open procedures to treat a broad range of spinal disorders, the company said. The technology allows real-time intraoperative viewing of instrumentation and implants relative to a patient’s anatomy for proper pedicle screw placement.

The technology is part of a partnership with DePuy and Brainlab.


Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

Only about 11% of spinal surgeons in the U.S. and Europe use advanced imaging technology, and DePuy is hoping to grow that number with the new system.

"The KICK System enhances less invasive surgery for the clinician who may not have access to expensive 3D imaging systems, but recognizes the need for advanced imaging to support a successful fusion procedure and help improve patient outcomes," Dan Wildman, platform leader at DePuy, said in a statement. "Through solutions such as the KICK System, we are improving access to care and creating and delivering clinical and economic value to healthcare systems worldwide."

By using a small, portable infrared camera with a computer and monitor, the system easily navigates between operating rooms and works together with existing X-ray equipment to support surgical workflow. The monitor displays up to four different X-ray images at one time to make X-ray equipment's repositioning to capture different views unnecessary, which reduces radiation exposure and surgery time.

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Silverback Therapeutics reeled in $85 million to advance its lead antibody-drug conjugate through the clinic and develop its earlier-stage pipeline.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.